The α2-adrenergic receptors in hypertension and heart failure: Experimental and clinical studies

Journal of Hypertension

Volumn 19, Issue 12, 2001, Pages 2115-2124

  Gavras, Irene ^a   Manolis, Athanasios J ^a   Gavras, Haralambos ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Salt induced hypertension; Sympathoexcitation; Sympathoinhibition; 2 adrenoceptor subtypes

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; SODIUM CHLORIDE; ADRENERGIC ALPHA AGONISTS; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADRENERGIC SYSTEM; ANTIHYPERTENSIVE ACTIVITY; CARDIOMYOPATHY; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENE DELETION; GENE EXPRESSION; GENE THERAPY; HEART FAILURE; HEART INFARCTION; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SYMPATHETIC TONE; ANIMAL; ARTERY; BLOOD PRESSURE; BRAIN; FORWARD HEART FAILURE; GENETICS; PHYSIOLOGY;

ADRENERGIC ALPHA-AGONISTS; ANIMAL; ARTERIES; BLOOD PRESSURE; BRAIN; CARDIAC OUTPUT, LOW; GENE DELETION; GENE EXPRESSION; GENE THERAPY; HUMAN; HYPERTENSION; RECEPTORS, ADRENERGIC, ALPHA; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034747422     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200112000-00001     Document Type: Review

References (76)

1. Adrenergic receptors-evolving concepts and clinical implications
2. 2-adrenergic receptors in hypertension
3. How does salt raise blood pressure? A hypothesis
4. Sodium-induced elevation of blood pressure in anephric rats
5. Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hypertension
6. Interaction of the sympathetic nervous system with vasopressin and renin in the maintenance of blood pressure
7. Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats
8. Salt-induced hypertension in chronic renal failure: Evidence for a neurogenic mechanism
9. + in normotensive and spontaneously hypertensive rats
10. Chronic cerebroventricular infusion of hypertonic sodium chloride in rats reduces hypothalamic sympatho-inhibition and elevates blood pressure
11. Central catecholamines and alpha-adrenoceptors in acute hypertension induced by intracerebroventricular hypertonic saline
12. Hypertensive response to saline microinjection in the area of the nucleus tractus solitarii of the rat
13. Alpha adrenoceptor agonists applied in the area of the nucleus tractus solitarii in the rat: Effect of anesthesia on cardiovascular responses
14. Hypertension, bradycardia, and pulmonary edema in the conscious rabbit after brainstem lesions coinciding with the A1 group of catecholamine neurons
15. Relative importance of sympathetic nerves and of circulating adrenaline and vasopressin in mediating hypertension and lesion of the caudal ventrolateral medulla in the rat
16. Hypertension, bradycardia, and pulmonary edema in the conscious rabbit after brainstem lesions coinciding with the A1 group of catecholamine neurons
17. Peripheral pressor systems in hypertension caused by nucleus tractus solitarius lesions
18. Interrelationship of sodium intake, hypertension and norepinephrine storage in the rat
19. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats
20. Adrenaline levels in brain stem nuclei and effects of a PNMT inhibitor on spontaneously hypertensive rats
21. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect
22. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat
23. Catecholamines and vasopressin in hindbrain nuclei of hypertension prone and resistant rats
24. Vasopressin-central nervous system interactions in the development of DOCA hypertension
25. Increased vasopressinergic activity following DOCA administration in the rat
26. Possible mechanisms of sodium-dependent hypertension: Volume expansion or vasoconstriction?
27. Adrenaline levels in brain stem nuclei and effects of a PNMT inhibitor on spontaneously hypertensive rats
28. Decrease in noradrenergic activity in hypothalamic nuclei during the development of spontaneous hypertension
29. Early changes in noradrenaline content of some brain nuclei in spontaneously hypertensive rats
30. High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats
31. Specific changes in hypothalamic alpha-adrenoceptors in young spontaneously hypertensive rats
32. Strain differences in rat brain epinephrine synthesis: Regulation of alphaadrenergic receptor number by epinephrine
33. Central alpha-adrenoceptors during the development of hypertension in rats on high and low salt intake
34. Sodium chloride-induced partial inhibition in vivo of alpha 2-adrenoceptor agonist function
35. Sodium responsiveness of central alpha 2-adrenergic receptors in spontaneously hypertensive rats
36. Cloning and expression of a rat brain alpha 2B-adrenergic receptor
37. Gene expression of catecholaminergic receptors in the central nervous system of hypertensive rats
38. Diverse tissue expression of rat alpha 2-adrenergic receptor genes
39. Localization of alpha 2A- and alpha 2B-adrenergic receptor subtypes in brain
40. Expression of alpha2-adrenergic receptors in normal and atherosclerotic rabbit aorta
41. Characterization of alpha-adrenoceptor gene expression in arterial and venous smooth muscle
42. Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog
43. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c
44. Central hypotensive effects of the alpha2a-adrenergic receptor subtype
45. Gene-targeting homing in on alpha2-adrenoceptor subtype function
46. Abnormal regulation of the sympathetic nervous system in alpha2A- adrenergic receptor knockout mice
47. Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension
48. Sympathoinhibitory function of the alpha (2A)-adrenergic receptor subtype
49. Amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype
50. Alpha-adrenergic receptors in hypertension
51. 2-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice
52. Role of the postsynaptic alpha (2)-adrenergic receptor subtypes in catecholamine-induced vasoconstriction
53. Is gene therapy for hypertension possible?
54. 2B-adrenergic receptor mRNA in the central nervous system
55. Facilitation of vagal reflex bradycardia by an action of clonidine on central a-receptors
56. Clonidine prevents insulin resistance and hypertension in obese dogs
57. The neurohumoral axis in congestive heart failure
58. Attenuation of prazosin effect on cardiac output in chronic heart failure
59. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
60. Clonidine in congestive heart failure: A vasodilator with negative inotropic effects
61. Acute and short-term effects of clonidine in heart failure
62. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: Assessment by a bilateral intracoronary infusion technique
63. New therapeutic strategies in chronic heart failure: Challenge of long-term beta-blockade
64. Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy
65. Chronic sympathetic suppression in the treatment of chronic congestive heart failure
66. Combined sympathetic suppression and angiotensin-converting enzyme inhibition in congestive heart failure
67. Neuroendocrine activation after acute MI
68. Benefits of central sympathetic suppression with clonidine after acute myocardial infaction
69. Acute effect of clonidine on left ventricular pressure-volume relation in hypertensive patients with diastolic heart dysfunction
70. The economics of therapeutic advances: The paradigm of sympathetic suppression in chronic heart failure
71. Effect of sympathoinhibition on exercise performance in patients with heart failure
72. Sympathetic inhibition with clonidine improves autonomic balance in congestive heart failure
73. Effect of clonidine on heart rate variability in congestive heart failure
74. Cardiac and systemic sympathetic activity in response to clonidine in human heart failure
75. Double-blind, placebo-controlled study of the effects of clonidine TTS on sympathetic nerve traffic and arterial baroreflex in heart failure patients
76. Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol